2013 DO Family Screening 
Annals of Family Medicine
NOVEMBER 20, 2024
The USPSTF recommends 1-time screening for AAA with ultrasonography in men aged 65 to 75 years who have ever smoked. (B Setting: Criteria Time Frame: 2013-01-01 to 2023-12-31. Setting: Criteria Time Frame: 2013-01-01 to 2023-12-31. Number of patients who meet inclusion criteria at Family Medicine Clinics: 6,551 Patients.
Concierge Choice Physicians
NOVEMBER 13, 2024
Greenough’s private cell number; patient advocacy and enhanced coordination with specialists and other health providers; and a comprehensive annual exam with customized screenings for each patient. “Welcoming my patients to this new style of medicine has been overwhelmingly positive,” Dr. Greenough adds.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Annals of Family Medicine
NOVEMBER 20, 2024
Additional searches included searches on Google Scholar, manual searches, citation tracking and reference list screening. Popay et al.’s ’s (2006) narrative synthesis was used to analyze and report the results. A consultation was conducted with eight members of the Deaf community to complete the results.
Annals of Family Medicine
NOVEMBER 20, 2024
Setting or Dataset: Data were derived from a survey dataset obtained from NHANES, specifically cross-sectional data from the 2013 to 2018 waves. Instrument: The NHANES assessed depression using the PHQ-9, a nine-item depression screening tool.
BMJ
NOVEMBER 26, 2021
Our study sample included 1039 eligible adults who were overweight or obese and reported prediabetes from pooled NHANES (2013-2018). However, screening diabetes and prediabetes management delivery are still a challenge in practice for the entire US population. Of those, 76.8%
Annals of Family Medicine
NOVEMBER 20, 2024
Setting or Dataset: A dataset was used, consisting of 350 long-term female breast cancer survivors included between 2013 and 2016 in general practices in the Netherlands. Conclusions ECG and NT-proBNP are inadequate diagnostic tools to screen for mild LVSD among asymptomatic long-term breast cancer survivors. and a specificity of 66.6%
The Health Policy Exchange
SEPTEMBER 16, 2013
Also, since the USPSTF is permitted to consider only clinical effectiveness, not cost effectiveness, it could potentially put taxpayers on the hook for cost-prohibitive screenings. They downplayed the potential harms of false positive screens (which affected 1 in 4 participants in the NLST), overdiagnosis, and radiation-induced cancers.
Expert insights. Personalized for you.
130 
Let's personalize your content